IL2 and neoplasm: Research has demonstrated that the combination of γδ T cells, IL-2, and [(HER2) 2Vγ-9] was employed in the treatment of tumor-bearing models established using the pancreatic cancer cell line PancTu-I and SCID Beige mice, resulting in significant inhibition of tumors in all mice (21).